3.4. Simultaneous EGFR Inhibition and ICB Indicate Slower Tumour Growth and Improved Antitumour Response over EGFR Inhibition Alone in EGFR-Driven NSCLC Model. This evidence concerns the gene EGFR and neoplasm.